Research Results and Observations BPC-157 (Body Protection Compound-157) is widely studied in experimental regenerative models: Tissue repair: Although large placebo-controlled phase 3 human trials are lacking, in vivo and pilot studies have examined tendon, muscle, ligament, and bone healing
Felt normal and not fatigued for the first time in a very long time
Genetics play a role in B12 deficiency Genetic polymorphisms such as MTHFR or MTRR can contribute to low usable B12
Vitamin B6 levels can be checked with a blood test and if found to be low, can be corrected with oral supplementation
For full details, see the FDA-approved Zepbound prescribing information
First, BPC157 has never been approved by the FDA for any medical indication